CRaTER enrichment for on-target gene editing enables generation of variant libraries in hiPSCs.
Cardiomyocytes
Disease modelling
Gene editing
Human induced pluripotent stem cells
Hypertrophic cardiomyopathy
MYH7
Journal
Journal of molecular and cellular cardiology
ISSN: 1095-8584
Titre abrégé: J Mol Cell Cardiol
Pays: England
ID NLM: 0262322
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
received:
15
12
2022
revised:
14
03
2023
accepted:
29
03
2023
pmc-release:
01
06
2024
medline:
16
5
2023
pubmed:
6
4
2023
entrez:
5
4
2023
Statut:
ppublish
Résumé
Standard transgenic cell line generation requires screening 100-1000s of colonies to isolate correctly edited cells. We describe CRISPRa On-Target Editing Retrieval (CRaTER) which enriches for cells with on-target knock-in of a cDNA-fluorescent reporter transgene by transient activation of the targeted locus followed by flow sorting to recover edited cells. We show CRaTER recovers rare cells with heterozygous, biallelic-editing of the transcriptionally-inactive MYH7 locus in human induced pluripotent stem cells (hiPSCs), enriching on average 25-fold compared to standard antibiotic selection. We leveraged CRaTER to enrich for heterozygous knock-in of a library of variants in MYH7, a gene in which missense mutations cause cardiomyopathies, and recovered hiPSCs with 113 different variants. We differentiated these hiPSCs to cardiomyocytes and show MHC-β fusion proteins can localize as expected. Additionally, single-cell contractility analyses revealed cardiomyocytes with a pathogenic, hypertrophic cardiomyopathy-associated MYH7 variant exhibit salient HCM physiology relative to isogenic controls. Thus, CRaTER substantially reduces screening required for isolation of gene-edited cells, enabling generation of functional transgenic cell lines at unprecedented scale.
Identifiants
pubmed: 37019277
pii: S0022-2828(23)00063-9
doi: 10.1016/j.yjmcc.2023.03.017
pmc: PMC10208587
mid: NIHMS1894100
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
60-71Subventions
Organisme : NHLBI NIH HHS
ID : F32 HL156361
Pays : United States
Organisme : NHLBI NIH HHS
ID : F32 HL150932
Pays : United States
Organisme : NHGRI NIH HHS
ID : T32 HG000035
Pays : United States
Organisme : NHLBI NIH HHS
ID : F32 HL164108
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL148081
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK017047
Pays : United States
Organisme : BLRD VA
ID : IK2 BX004642
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007266
Pays : United States
Commentaires et corrections
Type : UpdateOf
Informations de copyright
Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of Competing Interest C.E.M. is an equity holder in Sana Biotechnology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs or the United States Government.
Références
Circ Cardiovasc Genet. 2010 Apr;3(2):138-46
pubmed: 20124440
Nucleic Acids Res. 2017 May 19;45(9):5198-5207
pubmed: 28334759
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):
pubmed: 33649239
Nat Commun. 2021 Jun 21;12(1):3596
pubmed: 34155205
Cell. 1990 Sep 7;62(5):999-1006
pubmed: 1975517
Mol Biol Cell. 2017 Oct 15;28(21):2854-2874
pubmed: 28814507
Bioinformatics. 2014 Mar 1;30(5):614-20
pubmed: 24142950
Cell Rep Methods. 2022 Sep 22;2(10):100300
pubmed: 36313798
Stem Cell Reports. 2019 May 14;12(5):1145-1158
pubmed: 30956114
PLoS One. 2015 Apr 24;10(4):e0124633
pubmed: 25909470
Anat Rec (Hoboken). 2014 Sep;297(9):1670-80
pubmed: 25125180
Hum Mutat. 2019 Nov;40(11):2044-2056
pubmed: 31237724
Nucleic Acids Res. 2018 Feb 16;46(3):1375-1385
pubmed: 29267886
Nat Cell Biol. 2016 Oct;18(10):1031-42
pubmed: 27642787
JACC Basic Transl Sci. 2018 Dec 31;3(6):728-740
pubmed: 30623132
G3 (Bethesda). 2019 Nov 5;9(11):3683-3689
pubmed: 31558564
Circulation. 2019 Feb 5;139(6):799-811
pubmed: 30586709
Proc Natl Acad Sci U S A. 2015 Oct 13;112(41):12705-10
pubmed: 26417073
Stem Cell Reports. 2017 Mar 14;8(3):491-499
pubmed: 28238794
Physiol Genomics. 2020 Jul 1;52(7):293-303
pubmed: 32567507
Sci Rep. 2016 Jun 06;6:27459
pubmed: 27264908
Circ Res. 2017 May 12;120(10):1572-1583
pubmed: 28400398
Cell Stem Cell. 2018 Oct 4;23(4):586-598.e8
pubmed: 30290179
Stem Cells. 2020 Feb;38(2):174-186
pubmed: 31664757
Stem Cell Reports. 2017 Aug 8;9(2):615-628
pubmed: 28757163
Nucleic Acids Res. 2018 Nov 2;46(19):10195-10215
pubmed: 30239926
Nucleic Acids Res. 2019 Nov 4;47(19):e120
pubmed: 31428784
Cell Stem Cell. 2015 Feb 5;16(2):142-7
pubmed: 25658371
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Nat Genet. 2017 Jul;49(7):1035-1044
pubmed: 28581500
Nat Commun. 2022 Jul 21;13(1):4219
pubmed: 35864085
F1000Res. 2019 Nov 12;8:1911
pubmed: 32789000
Cell Stem Cell. 2016 May 5;18(5):573-86
pubmed: 27152442
Nat Protoc. 2018 Dec;13(12):3018-3041
pubmed: 30413796
PLoS One. 2015 Jan 14;10(1):e0116032
pubmed: 25587899
Int J Mol Sci. 2020 Jun 19;21(12):
pubmed: 32575374
Trends Genet. 2021 Dec;37(12):1109-1123
pubmed: 34509299
Cell. 1990 Sep 7;62(5):991-8
pubmed: 2144212
Cold Spring Harb Perspect Biol. 2013 May 01;5(5):a012757
pubmed: 23637284
J Mol Cell Cardiol. 2020 Aug;145:43-53
pubmed: 32531470
Stem Cell Res. 2021 Oct 21;57:102582
pubmed: 34688992
Circulation. 2018 Dec 11;138(24):2852-2854
pubmed: 30565988
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Stem Cell Reports. 2017 Nov 14;9(5):1423-1431
pubmed: 28988985
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722